Congestive Heart Failure - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

文章摘要

Glucose-lowering Drugs or Strategies, Atherosclerotic Cardiovascular Events, and Heart Failure in People With or at Risk of Type 2 Diabetes: An Updated Systematic Review and Meta-Analysis of Randomised Cardiovascular Outcome Trials
Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial
Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction
Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors
The Role of the Pericardium in Heart Failure: Implications for Pathophysiology and Treatment
The conductive function of biopolymer corrects myocardial scar conduction blockage and resynchronizes contraction to prevent heart failure
Exercise Intolerance in Patients With Heart Failure: JACC State-of-the-Art Review
Heart Failure and Atrial Fibrillation, Like Fire and Fury
Antithrombotics From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5)
The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5)

Consensus

2019 Oct 15;74(15):1966-2011.

JOURNAL：J Am Coll Cardiol.

2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure: A Report of the American College of Cardiology Solution Set Oversight Committee

Hollenberg SM, Warner Stevenson L, Ahmad T

3047

Keywords: ACC Expert Consensus Decision Pathway; CHF; angiotensin receptor-neprilysin inhibitors; beta blockers; comorbidities; diuretics; guideline-directed medical therapy; heart failure

FULL TEXT PDF